MedicaidPrior AuthMedium impact
Preferred Drug List – Basal Insulin
Illinois Medicaid - HFS·IL · Endocrinology, Family Medicine, Internal Medicine +1 more·Provider Notice
Effective date
Mar 31, 2008
We identified it
Jun 21, 2026
Summary
HFS (Illinois Medicaid) switched their preferred basal insulin from Lantus® to Levemir® multi-dose vials, which are covered without prior authorization. Temporary prior authorization overrides for existing Lantus® patients expire March 31, 2008, after which providers must submit PA requests for continued Lantus® use if medically necessary.
Action Required
By March 31, 2008: Providers must transition established Lantus® patients to Levemir® multi-dose vials or submit prior authorization requests for continued Lantus® use if medically necessary. Contact 1-800-252-8942 or fax 217-524-0404/217-524-7264 for PA requests. Update prescription protocols to default to Levemir® multi-dose vials for new basal insulin patients.